Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal One-Month Dosing of Lemborexant for Moderate Obstructive Sleep Apnea with Low Arousal Threshold
TCTR20260715008Phase 2Recruiting
- Sponsor
- Royal College of Physicians of Thailand
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Royal College of Physicians of Thailand. Started Jul 2026; status: recruiting.
02
Drugs
lemborexant
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on TCTR20260715008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260715008.